Vical other research news

VICL received a grant from the U.S Department of Defense under its Federal Defense Laboratory Diversification (FDLD) Program. The grant will provide $1 million per year for up to three years to support development of a malaria vaccine based on VICL's naked DNA vaccine technology.

A vaccine would consist of highly purified strands of DNA designed to instruct cells to make antigenic proteins that would result in protective immune responses. ...